🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Clorox Expands Dietary Supplements Business, Buys Nutranext

Published 03/13/2018, 11:10 PM
Updated 07/09/2023, 06:31 AM
GS
-
CLX
-
MS
-
ADM
-
UNFI
-
POST
-

The Clorox Company (NYSE:CLX) remains keen on making strategic partnerships with retail customers and evolving capabilities both in the physical world and online. With focus on investing in brands being a key part of its strategy, this consumer products’ maker recently agreed to purchase Nutranext — the Florida-based dietary supplements leader — for $700 million.

The deal is expected to expand the Clorox's dietary supplements business, thereby accelerating growth of its top brands in the fast-growing categories alongside focusing on health and wellness. It also acquired the RenewLife brand, digestive health leader in May 2016, which has been significantly contributing to the Clorox’s e-commerce and extended distribution in the retail businesses.

Expected to close in the fourth quarter of fiscal 2018, the deal is likely to reduce GAAP earnings by 7-11 cents per share in the quarter and 8-12 cents in fiscal 2019. Thereafter, the deal will be accretive to earnings in fiscal 2020. Clorox plans to finance the deal with cash and debt, while retaining its Debt/EBITDA ratio range of 2.0x to 2.5x.

Last year, Nutranext generated sales of nearly $200 million and the purchase price reflects about 3.5 times of sales. Around 90% of this multi-vitamins maker’s revenue is generated in the United States. Its products are sold in the retail and e-commerce channels and through the direct-to-consumer business. Nutranext markets multi-vitamins under the Rainbow Light brand, specialty minerals under the Natural Vitality brand and supplements for hair, skin and nails under the Neocell brand, among others.

Though Clorox has a solid earnings surprise history, this Zacks Rank #3 (Hold) company witnessed significant pressure on gross margin in the second quarter of fiscal 2018. The margin contraction can be attributed to elevated input costs for commodities and tightening of transportation market, which are likely to continue in fiscal 2018. However, we believe deals like this are likely to expand Clorox’s margins and the overall profitability.



In the past month, Clorox has inched up 0.1% faring better than the industry’s decline of 2%.

Three Hot Picks in the Consumer Staples Space

Post Holdings, Inc. (NYSE:POST) has a long-term earnings growth rate of 14% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

United Natural Foods, Inc. (NASDAQ:UNFI) , a Zacks Rank #1 stock, pulled off an average positive earnings surprise of 10.7% in the trailing four quarters.

Archer Daniels Midland Company (NYSE:ADM) has a Zacks Rank #2 (Buy) and delivered a positive earnings surprise of 17.1% in the last quarter.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion – more than a 3,800% increase in the previous 12 months. They’re now bigger than Morgan Stanley (NYSE:MS), Goldman Sachs (NYSE:GS) and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks. >>



United Natural Foods, Inc. (UNFI): Free Stock Analysis Report

Post Holdings, Inc. (POST): Free Stock Analysis Report

Clorox Company (The) (CLX): Free Stock Analysis Report

Archer Daniels Midland Company (ADM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.